Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 Aug 1;89(15):6983–6987. doi: 10.1073/pnas.89.15.6983

Importance of growth hormone for the induction of hepatic low density lipoprotein receptors.

M Rudling 1, G Norstedt 1, H Olivecrona 1, E Reihnér 1, J A Gustafsson 1, B Angelin 1
PMCID: PMC49629  PMID: 1495990

Abstract

This investigation was undertaken to determine the possible role of growth hormone (GH) in the hormonal regulation of hepatic low density lipoprotein (LDL) receptor expression. Treatment of normal rats with estrogen (ethynylestradiol, 5 mg/kg per day) increased the number of hepatic LDL receptors, and the LDL receptor mRNA levels were increased 2.4-fold. However, when hypophysectomized rats were treated with estrogen, the hepatic LDL receptor number and the mRNA levels only increased slightly. Treatment with GH was important to restore the induction of hepatic LDL receptors in hypophysectomized estrogen-treated rats. Further, the hypocholesterolemic effect of estrogen was abolished in hypophysectomized rats, and GH reversed this effect. To assess the effect of GH in humans, hepatic LDL receptor binding activity was determined in liver biopsy specimens from gallstone patients pretreated with GH (12 international units/day) prior to operation. GH administration induced hepatic LDL receptors approximately 2-fold, and this was accompanied by a 25% decrease in serum cholesterol. The LDL receptor stimulation caused by GH treatment was of similar magnitude as that observed upon 3 weeks of treatment with an established hypolipidemic drug (pravastatin or simvastatin). The data show that GH has an important role in the regulation of hepatic LDL receptors and suggest that GH secretion may be important for the control of plasma LDL levels in humans.

Full text

PDF
6983

Images in this article

6985Image
on p.6985
6985Image
on p.6985
6986Image
on p.6986
6986Image
on p.6986

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asplin C. M., Faria A. C., Carlsen E. C., Vaccaro V. A., Barr R. E., Iranmanesh A., Lee M. M., Veldhuis J. D., Evans W. S. Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1989 Aug;69(2):239–245. doi: 10.1210/jcem-69-2-239. [DOI] [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  3. Brown M. S., Goldstein J. L. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986 Apr 4;232(4746):34–47. doi: 10.1126/science.3513311. [DOI] [PubMed] [Google Scholar]
  4. Burnette W. N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981 Apr;112(2):195–203. doi: 10.1016/0003-2697(81)90281-5. [DOI] [PubMed] [Google Scholar]
  5. Chao Y. S., Windler E. E., Chen G. C., Havel R. J. Hepatic catabolism of rat and human lipoproteins in rats treated with 17 alpha-ethinyl estradiol. J Biol Chem. 1979 Nov 25;254(22):11360–11366. [PubMed] [Google Scholar]
  6. Ericsson S., Eriksson M., Vitols S., Einarsson K., Berglund L., Angelin B. Influence of age on the metabolism of plasma low density lipoproteins in healthy males. J Clin Invest. 1991 Feb;87(2):591–596. doi: 10.1172/JCI115034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eriksson M., Berglund L., Rudling M., Henriksson P., Angelin B. Effects of estrogen on low density lipoprotein metabolism in males. Short-term and long-term studies during hormonal treatment of prostatic carcinoma. J Clin Invest. 1989 Sep;84(3):802–810. doi: 10.1172/JCI114239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Friedman M., Byers S. O., Elek S. R. Pituitary growth hormone essential for regulation of serum cholesterol. Nature. 1970 Jan 31;225(5231):464–467. doi: 10.1038/225464a0. [DOI] [PubMed] [Google Scholar]
  9. Friedman M., Byers S. O., Rosenman R. H., Li C. H., Neuman R. Effect of subacute administration of human growth hormone on various serum lipid and hormone levels of hypercholesterolemic and normocholesterolemic subjects. Metabolism. 1974 Oct;23(10):905–912. doi: 10.1016/0026-0495(74)90039-0. [DOI] [PubMed] [Google Scholar]
  10. Goldstein J. L., Brown M. S. Regulation of the mevalonate pathway. Nature. 1990 Feb 1;343(6257):425–430. doi: 10.1038/343425a0. [DOI] [PubMed] [Google Scholar]
  11. Grundy S. M., Vega G. L., Bilheimer D. W. Kinetic mechanisms determining variability in low density lipoprotein levels and rise with age. Arteriosclerosis. 1985 Nov-Dec;5(6):623–630. doi: 10.1161/01.atv.5.6.623. [DOI] [PubMed] [Google Scholar]
  12. Gustafsson J. A., Mode A., Norstedt G., Skett P. Sex steroid induced changes in hepatic enzymes. Annu Rev Physiol. 1983;45:51–60. doi: 10.1146/annurev.ph.45.030183.000411. [DOI] [PubMed] [Google Scholar]
  13. Hay R. V., Pottenger L. A., Reingold A. L., Getz G. S., Wissler R. W. Degradation of I 125 -labelled serum low density lipoprotein in normal and estrogen-treated male rats. Biochem Biophys Res Commun. 1971 Sep 17;44(6):1471–1477. doi: 10.1016/s0006-291x(71)80251-6. [DOI] [PubMed] [Google Scholar]
  14. Henriksson P., Stamberger M., Eriksson M., Rudling M., Diczfalusy U., Berglund L., Angelin B. Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol-fed rabbit. Eur J Clin Invest. 1989 Aug;19(4):395–403. doi: 10.1111/j.1365-2362.1989.tb00248.x. [DOI] [PubMed] [Google Scholar]
  15. Jansson J. O., Edén S., Isaksson O. Sexual dimorphism in the control of growth hormone secretion. Endocr Rev. 1985 Spring;6(2):128–150. doi: 10.1210/edrv-6-2-128. [DOI] [PubMed] [Google Scholar]
  16. Johnson R. J. Diminution of pulsatile growth hormone secretion in the domestic fowl (Gallus domesticus): evidence of sexual dimorphism. J Endocrinol. 1988 Oct;119(1):101–109. doi: 10.1677/joe.0.1190101. [DOI] [PubMed] [Google Scholar]
  17. Kovanen P. T., Brown M. S., Goldstein J. L. Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol. J Biol Chem. 1979 Nov 25;254(22):11367–11373. [PubMed] [Google Scholar]
  18. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  19. Langer T., Strober W., Levy R. I. The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J Clin Invest. 1972 Jun;51(6):1528–1536. doi: 10.1172/JCI106949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ma P. T., Yamamoto T., Goldstein J. L., Brown M. S. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha-ethinyl estradiol. Proc Natl Acad Sci U S A. 1986 Feb;83(3):792–796. doi: 10.1073/pnas.83.3.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Mode A., Gustafsson J. A., Jansson J. O., Edén S., Isaksson O. Association between plasma level of growth hormone and sex differentiation of hepatic steroid metabolism in the rat. Endocrinology. 1982 Nov;111(5):1692–1697. doi: 10.1210/endo-111-5-1692. [DOI] [PubMed] [Google Scholar]
  22. Mode A., Norstedt G., Simic B., Eneroth P., Gustafsson J. A. Continuous infusion of growth hormone feminizes hepatic steroid metabolism in the rat. Endocrinology. 1981 Jun;108(6):2103–2108. doi: 10.1210/endo-108-6-2103. [DOI] [PubMed] [Google Scholar]
  23. Norstedt G., Wrange O., Gustafsson J. A. Multihormonal regulation of the estrogen receptor in rat liver. Endocrinology. 1981 Apr;108(4):1190–1196. doi: 10.1210/endo-108-4-1190. [DOI] [PubMed] [Google Scholar]
  24. Reihnér E., Rudling M., Ståhlberg D., Berglund L., Ewerth S., Björkhem I., Einarsson K., Angelin B. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med. 1990 Jul 26;323(4):224–228. doi: 10.1056/NEJM199007263230403. [DOI] [PubMed] [Google Scholar]
  25. Rosén T., Bengtsson B. A. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990 Aug 4;336(8710):285–288. doi: 10.1016/0140-6736(90)91812-o. [DOI] [PubMed] [Google Scholar]
  26. Rudling M. Hepatic mRNA levels for the LDL receptor and HMG-CoA reductase show coordinate regulation in vivo. J Lipid Res. 1992 Apr;33(4):493–501. [PubMed] [Google Scholar]
  27. Rudman D., Kutner M. H., Rogers C. M., Lubin M. F., Fleming G. A., Bain R. P. Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest. 1981 May;67(5):1361–1369. doi: 10.1172/JCI110164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Russell W. E. Growth hormone, somatomedins, and the liver. Semin Liver Dis. 1985 Feb;5(1):46–58. doi: 10.1055/s-2008-1041757. [DOI] [PubMed] [Google Scholar]
  29. Salomon F., Cuneo R. C., Hesp R., Sönksen P. H. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 1989 Dec 28;321(26):1797–1803. doi: 10.1056/NEJM198912283212605. [DOI] [PubMed] [Google Scholar]
  30. Semenkovich C. F., Ostlund R. E., Jr Estrogens induce low-density lipoprotein receptor activity and decrease intracellular cholesterol in human hepatoma cell line Hep G2. Biochemistry. 1987 Aug 11;26(16):4987–4992. doi: 10.1021/bi00390a016. [DOI] [PubMed] [Google Scholar]
  31. Smith J. R., Osborne T. F., Goldstein J. L., Brown M. S. Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene. J Biol Chem. 1990 Feb 5;265(4):2306–2310. [PubMed] [Google Scholar]
  32. Soutar A. K., Harders-Spengel K., Wade D. P., Knight B. L. Detection and quantitation of low density lipoprotein (LDL) receptors in human liver by ligand blotting, immunoblotting, and radioimmunoassay. LDL receptor protein content is correlated with plasma LDL cholesterol concentration. J Biol Chem. 1986 Dec 25;261(36):17127–17133. [PubMed] [Google Scholar]
  33. Tannenbaum G. S., Martin J. B. Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat. Endocrinology. 1976 Mar;98(3):562–570. doi: 10.1210/endo-98-3-562. [DOI] [PubMed] [Google Scholar]
  34. Thorner M. O., Vance M. L. Growth hormone, 1988. J Clin Invest. 1988 Sep;82(3):745–747. doi: 10.1172/JCI113673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wade D. P., Knight B. L., Soutar A. K. Regulation of low-density-lipoprotein-receptor mRNA by insulin in human hepatoma Hep G2 cells. Eur J Biochem. 1989 May 15;181(3):727–731. doi: 10.1111/j.1432-1033.1989.tb14784.x. [DOI] [PubMed] [Google Scholar]
  36. Waxman D. J., Pampori N. A., Ram P. A., Agrawal A. K., Shapiro B. H. Interpulse interval in circulating growth hormone patterns regulates sexually dimorphic expression of hepatic cytochrome P450. Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6868–6872. doi: 10.1073/pnas.88.15.6868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Windler E. E., Kovanen P. T., Chao Y. S., Brown M. S., Havel R. J., Goldstein J. L. The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E. J Biol Chem. 1980 Nov 10;255(21):10464–10471. [PubMed] [Google Scholar]
  38. Winer L. M., Shaw M. A., Baumann G. Basal plasma growth hormone levels in man: new evidence for rhythmicity of growth hormone secretion. J Clin Endocrinol Metab. 1990 Jun;70(6):1678–1686. doi: 10.1210/jcem-70-6-1678. [DOI] [PubMed] [Google Scholar]
  39. Yamamoto T., Davis C. G., Brown M. S., Schneider W. J., Casey M. L., Goldstein J. L., Russell D. W. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell. 1984 Nov;39(1):27–38. doi: 10.1016/0092-8674(84)90188-0. [DOI] [PubMed] [Google Scholar]
  40. van Driel I. R., Davis C. G., Goldstein J. L., Brown M. S. Self-association of the low density lipoprotein receptor mediated by the cytoplasmic domain. J Biol Chem. 1987 Nov 25;262(33):16127–16134. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES